Club cell protein (CC16) is significantly reduced in newborn rats with sepsis.
Introduction
Sepsis is a common clinical disease in pediatric intensive care units (PICU) and more than 50% of patients with sepsis have different degrees of brain injury (Zhang et al., 2012) . Clinical manifestations of sepsis-induced brain injury are mainly characterized by a series of neurological disorders, including neuroendocrine dysfunction and autonomic failure, delirium, seizures, coma or even death (Gofton and Young, 2012) . Numerous factors play a role in the underlying mechanism of sepsis, such as inflammation (Jacob et al., 2011) , oxidative stress (Comim et al., 2011) , apoptosis (Kafa and Uysal, 2010; Semmler et al. 2005) , autophagy (Su et al., 2015) , mitochondrial dysfunction (Gofton and Young, 2012) , and cerebral microcirculatory obstruction (Schramm et al., 2012; Backer et al., 2013) . Thus, the occurrence of this disease may result from a combination of the above pathogenic factors at different stages of sepsis.
Studies have shown that mitogen-activated protein kinases (MAPKs) are closely related to inflammation response and oxidative stress Ma et al., 2014) . The p38MAPK is one of the most important kinases in the MAPK signaling pathway. It can also mediate apoptosis and autophagy associated with the phosphorylation of its downstream proteins (Zhao et al., 2013; Liu et al., 2018; Sreekanth et al., 2016) . In a cecal ligation and puncture (CLP)-induced sepsis rat model, the use of a p38MAPK inhibitor was shown to increase the chances of survival, and this signaling pathway was confirmed to play an important role (O'Sullivan et al., 2009) . Simultaneously, inflammation (Jacob et al., 2011) , oxidative stress (Barichello et al., 2007) , apoptosis (Tang et al. 2017) , and autophagy (Su et al., 2015) occur in the brain as a result of sepsis. However, the relationship between these pathogenic factors and the p38MAPK signaling pathway is poorly understood.
Club cell protein (CC16) is mainly secreted by the non-ciliated, nonmucous-secreting bronchiolar cells, and is known to have anti-inflammatory (Cowan et al., 2010) and antioxidant effects (Plopper et al., 2006) . Furthermore, CC16 is distributed throughout the body through blood, cerebrospinal fluid, amniotic fluid, and other body fluids (Boers et al., 1996; De Jongh et al., 1998) . A previous study showed that, in a rat model of sepsis, the concentration of CC16 in cardiac tissue was significantly lower than that in the control group, which may be one of the causes of sepsis-induced cardiac injury .
CC16 is also an important endogenous self-regulatory molecule, which can easily be produced and stabilized by recombination. Consequently, recombinant rCC16 (rCC16) serves an effective therapeutic (Hiemstra and Bourdin, 2014) , because it suppresses the production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-8, by inhibiting the nuclear factor κB (NF-κB) and p38MAPK pathways in RAW264.7 cells (Pang et al., 2017) . Moreover, rCC16 can be used in premature infants, newborn lambs, in addition to animal disease models, but the issues pertaining to its safety or tolerance have not yet been reported (Levine et al., 2005; Shashikant et al., 2005; Chandra et al., 2003) .
Therefore, this study aimed to investigate the presence of CC16 in brain tissue of rats with sepsis, and to determine whether CC16 played a role in inflammation, oxidative stress, apoptosis and autophagy. In addition, we also determined whether rCC16 inhibited the p38MAPK signaling pathway, so as to provide a basis for the application of rCC16 in the treatment of sepsis induced brain injury.
Experimental procedures

Animals and treatments
Ten-day-old male SD rats (20-22 g) were purchased from Sichuan Jianyang Dashuo Animal Science and Technology Co., Ltd. The Research Animal Care Committee of Sichuan University approved all research protocols, and the methods were carried out in accordance with approved guidelines and regulations. All rats were housed with free access to food and water at 22-25°C and 55-58% relative humidity, on a 12 h light/dark cycle. Every effort was made to minimize the number and suffering of the animals used.
SD rats were randomly distributed to the sham group, CLP group, CLP + Veh group, CLP + rCC16 group, CLP + rCC16 + SB group and CLP + rCC16 + AN group. Each group was the randomly divided into 3, 6, 12, 24 and 48 h groups. All groups except the sham group received CLP to establish a mid-grade sepsis model. Sepsis was induced by CLP as previously reported (Rittirsch et al., 2009) . After the procedure, antibiotic treatment, clindamycin (150 mg/kg) and ceftriaxone (50 mg/kg) were given intraperitoneally. Right after the models were built, the rats in the CLP + Veh group received 5 µl vehicle (DMSO, Cell Signaling Technology, Beverly, MA, USA) into the lateral cerebral ventricle; for the three CLP + rCC16 groups, the rats were separately injected with 5 µl of 0.10, 0.25, or 0.50 mg/kg rCC16 (Sangon Biotech, Shanghai, China, soluble in saline) into the lateral cerebral ventricles. The rCC16 was expressed in e. coli-Rosetta (DE3) by referring to the gene sequence of CC16 in norvegicus. After a large number of induced expression of fusion protein, rCC16 was purified to 95%, the endotoxin was controlled, and the bacteria were filtered and sterilized. Secretory phosolipase A2 Assay Kit (Abcam, Cambridge, MA, UK) revealed that rCC16 can inhibit secretory phosolipase A2 in rats, its effective activity was 82%. The dosages of rCC16 were graded based on the concentration of CC16 in the brain of normal rats in the pre-experiment. The rats in the CLP + rCC16 + SB group were injected with 5 µl rCC16 and 5 µl p38MAPK signaling pathway inhibitor-SB203580 (Enzo Life, Farmingdale, NY, USA, soluble in 1% DMSO, prepared a solution with a concentration of 0.1 nM) into the lateral cerebral ventricle (Kim et al., 2004) ; and the rats in the CLP + rCC16 + AN group were injected with 5 µl rCC16 and 5 µl p38MAPK signaling pathway agonist-anisomycin (Millipore, Danvers, MA, USA, soluble in 1% DMSO, prepared a solution with a concentration of 0.5 mg/µl) into the lateral cerebral ventricle (Naghdi et al., 2003) . In the sham group, the rats were treated in the same way as the CLP group, except that the cecum was neither ligated nor punctured. Each animal was administered 1 ml 0.9% (w/v) saline by intraperitoneal injection to antishock.
Evaluation of survival percentage
After the operation, rats were raised in a sterile environment and had free access to food and water. We observed and recorded the mental and motor status, wound healing, and infection status of the rats before execution. The survival percentage was measured at postoperative different time points.
Evaluation of vital parameters
An indwelling tube was placed within the rat' femoral artery, and connected a biological signal recorder (iWorx Systems, Dover, NH, USA) for continuous monitoring of mean arterial pressure (MAP) and heart rate (HR) after CLP.
Neurological assessment
Neurobehavioral testing was performed to evaluate the somatomotor function, including the auricular reflex, corneal reflex, righting reflex, wagging tail reflex, and escape reflex. A "0" score was given for no reflex, "1" for weak reflex (loss of reflex for 10 sec), "2" for normal reflex; with a maximal obtainable score of 10 points for each rat. Lower the score, worse the brain injury (Kafa and Uysal, 2010) .
2.5. Measurement of IL-1β, IL-6, TNF-α, SOD and MDA Rats were decapitated at specific time points and the brain tissues were quickly eviscerated; the cortex and hippocampus were then isolated on the ice and stored at −80°C until use. Interleukin (IL)-1 beta rat ELISA kit (ab100768, Abcam), IL-6 rat ELISA kit (ab100772, Abcam), tumor necrosis factor (TNF)-alpha rat ELISA kit (ab46070, Abcam), superoxide dismutase (SOD) activity assay kit (ab65354, Abcam) and lipid peroxidation (malondialdehyde, MDA) assay kit (ab118970, Abcam) were respectively used to detect the corresponding indicators. Absorbance values were analyzed at different wavelengths using microplate readers (Thermo Fisher Scientific, MA, USA).
Histological examination
Rats were deeply anesthetized by an intraperitoneal injection of 10% (w/v) chloral hydrate then transcardially perfused with 100 ml of 0.9% (w/v) normal saline, followed by 100 ml of 4% (w/v) paraformaldehyde. After the brain tissue was harvested and fixed in 4% (w/ v) paraformaldehyde at 4°C for 24-48 h, each sample was cut in a coronal plane which is from the optic chiasma through to the back (1 cm long); the segment of the brain tissue was then embedded in paraffin. Finally, the samples were sectioned (6 µm) and stained with hematoxylin-eosin (HE), and an optical microscope (Leica, Mannheim, Germany) was used to observe the pathological changes.
Western blot analysis
Rats in each group were anesthetized by an intraperitoneal injection of 10% (w/v) chloral hydrate and decapitated at 3, 6, 12, 24 and 48 h post-operation; the brain tissues were then quickly removed and the cortex and hippocampus were isolated on the ice. Each sample was deposited in ice-cold lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 10 mg/L NP-40, 0.1% protease inhibitor cocktail (Roche)). Tissue samples were homogenized on ice and centrifuged at 12,000g for 30 min at 4°C. The supernatant was collected and stored at −80°C. The BAC assay (Sigma Aldrich, St. Louis, MO) was used to analyze the protein content of all samples and ensure that the protein loading of each sample was consistent. Equal amounts (20 µg) of each sample were electrophoresed on different densities of SDS-polyacrylamide gels (15%), the target proteins were isolated and then transferred onto a polyvinylidene difluoride membrane (Millipore). The membranes were incubated with the primary antibodies in 2.5% (w/v) fetal bovine serum at 4°C overnight. These antibodies included: rabbit anti-CC16 polyclonal antibody (1:500, Abcam), rabbit anti-MAPK activated protein kinase2 (MAPKAPK2) polyclonal antibody (1: 1000, Abcam), rabbit anti-MAPKAPK2 (phospho T334) polyclonal antibody (1: 1000, Abcam), rabbit anti-cleaved caspase-3 (CC3) polyclonal antibody (1: 500, Cell Signaling Technology, USA), mouse anti-B cell lymphoma-2 (Bcl-2) polyclonal antibody (1:500, R&D Systems), rabbit anti-Bcl-2 associated X (Bax) monoclonal antibody (1: 1000, Cell Signaling Technology), rabbit anti-microtubule-associated protein light chain 3 (LC3) polyclonal antibody (1: 1000, Abcam), rabbit anti-sequesto-some1/p62 (SQSTM1/p62) monoclonal antibody (1: 1000, Abcam). After washing three times in TBST, the membranes were incubated in the dark with the appropriate horseradish-peroxidase conjugated secondary antibodies (1: 5000, Santa Cruz, Dallas, TX, USA) in 2.5% (w/v) fetal bovine serum at room temperature for 1 h. Band visualization within the linear range was performed by the ECL kit (Millipore) and a gel imaging analysis system (Bio-Rad, USA). In addition, the intensity of each band was quantitatively analyzed using the Image J Analyzer Software and the density ratio represented the relative intensity of each band against tubulin or GAPDH (as internal controls).
Immunofluorescence staining
Rats were deeply anesthetized by an intraperitoneal injection of 10% (w/v) chloral hydrate at 3, 6, 12, 24 and 48 h post-operation and transcardially perfused with 100 ml of 0.9% (w/v) saline, followed by that with 100 ml of 4% (w/v) paraformaldehyde; then the brain tissues were isolated. After harvesting, the brain tissue was fixed in 4% (w/v) paraformaldehyde at 4°C for 24-48 h, embedded in 2.5% (w/v) agarose, and cut into 40-µm sections using an oscillate slicer (Leica). The sections were washed three times with PBS and blocked for 30 min in 0.3% (v/v) Triton X-100 and for 1 h in PBS containing 2% (v/v) fetal calf serum at room temperature. Next, primary antibodies diluted in PBS containing 1% (v/v) fetal calf serum were added to the sections, which were then incubated at 4°C overnight. The primary antibodies included: rabbit anti-CC16 polyclonal antibody (1:800, Abcam), mouse anti-neuron specific nuclear (NeuN) monoclonal antibody (1:500, Abcam), chicken anti-glial fibrillary acidic protein (GAPF) polyclonal antibody (1:500, Abcam), mouse anti-oligodendrocyte transcription factors 2 (Olig2) monoclonal antibody (1:250, Abcam), and mouse antiionized calcium binding adaptor molecule 1 (Iba1) monoclonal antibody (1: 200, Millipore, MA, USA). Meanwhile, during each fluorescence staining, the control group was added, using the corresponding non-immune control antibodies instead of primary antibodies, to observe the false positive of the brain section. After incubation, the sections were washed with PBS for three times, and the appropriate secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA): Cy3-conjugated donkey anti-rabbit IgG (1:500), DyLight 488-conjugated donkey anti-chicken IgG (1: 500), or DyLight 488-conjugated donkey anti-mouse IgG (1: 500) were added, following which the sections were incubated for 2 h in the dark at room temperature. The sections were then washed with PBS for three times and nuclear stained with DAPI (1:500, Beyotime, Haimen, China) for 5 min in the dark at room temperature. The sections were then mounted onto glass slides. An anti-fluorescence quenching agent (Beyotime) was added and the sections covered with cover slips. The fluorescence microscopy digital images were captured with a confocal laser scanning microscope (Olympus, Tokyo, Japan) and FV10-ASW-4.2 software (Olympus), and data analysis was conducted using Image J.
Annexin V-FITC/PI staining
After the brain tissue was cut up mechanically, it was filtered with a 300-mesh filter cloth, centrifuged at 250g for 5 min, and the cell fragments were blown off by the dropper. The cell concentration was adjusted to 10 6 /ml with PBS. 100 μl single-cell suspension was taken and centrifuged at 250g for 5 min. The supernatant was discarded and 200 μl 1× combined buffer was added to resuspend the cells. 5 μl Annexin V-FITC and 10 μl PI fluorescence (Invitrogen, Carlsbad, CA) were added and stained at room temperature for 10 min, respectively. Then 400 μl binding buffer was added, the cells were suspended, CytoFLEX 60 cytograph (Backman Coulter, USA) was used immediately, and Kaluza2.1 software was used to analyze the data. The percentage of apoptotic cells was the sum of B++ (Annexin v-fitc +/PI +) and B+− (Annexin v-fitc +/PI−).
Transmission electron microscopy (TEM)
From the coronal plane of the rat brain tissue, a sample about the size of a grain of rice was cut after the crossing of the optic nerve, and fixed in 2.5% (w/v) glutaraldehyde solution for 24-36 h. It was then washed with PBS, fixed in 3% (w/v) glutaraldehyde and 1% (w/v) phosphate-buffer osmium tetroxide solution for 2 h, embedded in epoxy resin, cut into 0.12-µm sections, and stained with 0.2% (w/v) lead citrate and 1% (w/v) uranium dioxide acetate to observe the ultrastructure for neuronal autophagy using HC-1 TEM (Hitachi, Japan).
Statistical analysis
Values are expressed as mean ± SEM. Statistical Package for Social Sciences (SPSS, Version 19.0, Chicago, IL, USA) was used for statistical analysis. Fisher's exact probability test in a 2 × 2 table was used to analyze the survival percentage of the rats. The statistical significance between the samples of each group was analyzed by one-way ANOVA followed by the Student-Newman-Keuls test. P < 0.05 was considered to indicate statistical significance.
Results
Changes in neonatal rats with sepsis
General condition deteriorated
We observed the sham-operated rats and the CLP rats, and found that the postoperative activities of the sham-operated rats were normal, while the CLP rats exhibited delays in waking up, a listless spirit, a curled up body, reduced intake of food and water, loose and lackluster hair, and loose stools; additionally, these rats no longer huddle for warmth.
Survival percentage decreased
We calculated also the survival percentage of rats within 48 h after surgery. The survival percentage of rats in the sham group was 100%, while the survival rate of the CLP rats at 48 h was only 20% (P < 0.05, Fig. 1 ).
Vital signs worsen
To determine whether the sepsis model was successfully established, we monitored the MAP and HR of the rats at different time points. The MAP of the sham-operated rats was the highest and the HR was the lowest. The MAP of CLP rats gradually decreased, whereas HR gradually increased, peaking at 12 h and 24 h, respectively (P < 0.05, Fig. 2A and B ).
Neurobehavioral scores decreased
Additionally, in order to observe the effect of sepsis-associated brain injury on neural reflex in rats, we also evaluated the neurobehavioral scores. We found that compared with the sham-operated rats, the score of the CLP rats decreased significantly from 3 h, with the lowest score at 24 h (P < 0.05, Fig. 3A ).
Pathological changes were obvious in cortex and hippocampus
Meanwhile, we observed differences in the brain tissue between the sham-operated rats and the CLP rats by HE staining. In the sham group, the brain structure of the rats was complete at the macroscopic level, with a smooth surface, sufficient elasticity, and abundant blood vessels. At the microscopic level, the cortex and hippocampus were well structured, and the cells were abundant and arranged in an orderly fashion. In the rats following CLP surgery, the macroscopical structure of the brain was loose and necrotic exhibiting cerebral tissue edema. The cortical structure was irregular, with a decreased number of cells and widened pericapillary space. The cells showed vacuolar changes, some nucleus pycnosis, and the Nissl bodies dissolved and disappeared. The hippocampal tissue was loose and the cells were disordered and swollen, presenting as acute traumatic changes ( Fig. 4) .
3.1.6. Inflammation and oxidative stress were increased in the supernatant of cortex and hippocampus
In order to monitor the changes in inflammation and oxidative stress in the rat brain tissue, the following indicators were monitored: at different time points, the IL-1β, IL-6, and TNF-α levels in the cortex and hippocampus of the rat sepsis model were all higher than those of the sham-operated rats (P < 0.05, Fig. 5A ). Compared with the sham-operated rats, the SOD inhibition rate in the cortex and hippocampus of the rat sepsis model was lower (except hippocampus-3 h, 6 h), with lowest rate observed at 12 h; malondialdehyde (MDA) levels increased and peaked at 12 h (P < 0.05, Fig. 5B ). These results suggest that inflammation and oxidative stress are activated in brain tissue during sepsis.
Increased apoptosis in cortex and hippocampus
Whereafter, in order to study the apoptosis in the brain of the rat sepsis model, western blot analysis was used to detect the expression of CC3, Bcl-2 and Bax; Annexin V-FITC/PI staining was employed to observe apoptosis rates in the brain. In the cortex and hippocampus, compared with sham-operated rats, CC3 expression was higher in the rat sepsis model at all time points, and was the highest at 12 h (P < 0.05, Fig. 6A ); Bax expression in the rat sepsis model also increased significantly from 6 h to 12 h, where it peaked and then decreased (P < 0.05, Fig. 6C ). On the contrary, compared with shamoperated rats, Bcl-2 expression in the rat sepsis model decreased significantly from 6 h to 12 h, at which point the expression level was the lowest in both the cortex and hippocampus (P < 0.05, Fig. 6B ). Annexin V-FITC /PI staining detection: the apoptosis rate in brain tissues is the sum of the early apoptosis rate (B+−) and the late apoptosis rate (B++). In the cortex and hippocampus, the apoptosis rate of sepsis rats was significantly higher than that of the sham group (P < 0.05, Fig. 6D ).
Autophagy activation in cortex and hippocampus
At the same time, in order to study autophagy in the brain of rats, we monitored the relevant proteins through western blot analysis and observed the process of intracellular autophagy by using a TEM. In the cortex and hippocampus of the rat sepsis model, the expression of LC3 II was higher than that of sham-operated rats (P < 0.05, Fig. 7A ), while the expression of SQSTM1/p62 was significantly lower (P < 0.05, Fig. 7B ). No autophagosomes were observed with TEM in the nerve cells of the sham-operated rats in the cortex and hippocampus, with a uniform distribution of organelles and normal appearance (Fig. 7C ). Large autophagosomes enclosing damaged organelles or proteins and lysosomal invasion of organelles were observed in the rat sepsis model. Mitochondria were swollen and tended to be spherical or deformed, with internal structural disorders, and the endoplasmic reticulum and Golgi apparatus were damaged and ruptured ( Fig. 7C ). Combined with the above manifestations, we believe that autophagy of brain nerve cells is activated in sepsis, but not fully activated.
3.1.9. The p38MAPK signaling pathway was activated in the cortex and hippocampus
The p38MAPK signaling pathway inhibitor SB203580 cannot directly inhibit the phosphorylation of p38MAPK, but it can inhibit the phosphorylation of its downstream MAPKAPK2; hence, we observed the activity of the p38MAPK signaling pathway by detecting MAPKAPK2 and p-MAPKAPK2 (Sreekanth et al. 2016 ). In the cortex and hippocampus, the total amount of MAPKAPK2 in each group did not change significantly, but compared with the sham group, the rat sepsis model (except in the cortex at 12 h) exhibited higher levels of p-MAPKAPK2/ MAPKAPK2 (P < 0.05, Fig. 8 ). In sepsis, the brain's p38MAPK signaling pathway is activated.
CC16 expression was decreased in cortex and hippocampus
As a protein closely related to the p38MAPK signaling pathway, CC16 may regulate inflammatory, oxidative stress, apoptosis, autophagy and other cell activities related to sepsis through this signaling pathway (Jacob et al., 2011; Comim et al., 2011; Kafa and Uysal, 2010; Semmler et al., 2005; Su et al., 2015; Pang et al., 2017) . To investigate the protective effect of CC16 on sepsis-induced brain injury, we studied the expression of CC16 in neonatal brain of normal rats and sepsis rats.
Western blotting revealed that CC16 expression levels were highest in the brain of sham-operated rats. In CLP rats, CC16 expression decreased gradually with time, with the CC16 expression lowest at 12 h in cortex and 24 h in hippocampus, followed by a slight recovery (P < 0.05, Fig. 9A ). On the other hand, to determine the localization of CC16, we also conducted immunofluorescence co-staining of CC16 with NeuN, GAPF, Olig2 and Iba1 in the cortex and hippocampus. Co-localization analysis revealed that CC16 was always closely localized to the Fig. 4 . Pathological changes in the brain tissue after CLP surgery. The cortex and hippocampus of the sham-operated and CLP-12 h groups were observed by HE staining. Scale bar indicates 50 μm; n = 6 for each group in each experiment. Fig. 5 . IL-1β, IL-6, TNF-α, SOD and MDA levels in brain tissue after CLP surgery. The levels of IL-1β, IL-6, TNF-α, SOD, and MDA in the cortex and hippocampus were determined in the sham group and the CLP group at 3, 6, 12, 24, and 48 h. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs sham group in the cortex; # P < 0.05 vs sham group in the hippocampus. neurons (NeuN), followed by astrocytes (GAPF), oligodendrocytes (Olig2), and microglia (Iba1) in the cortex and hippocampus of shamoperated and CLP rats (P < 0.05, Fig. 9B-D) . Moreover, after observing the fluorescence signal, CC16 expression in the brain of CLP rats was decreased significantly compared to sham-operated rats, which was consistent with the results of western blotting.
Effect of rCC16 treatment in neonatal rats with sepsis
The above experiments demonstrated that CC16 decreased during sepsis and that the overall condition and pathological changes worsened, accompanied by activation of the p38MAPK signaling pathway, inflammation, oxidative stress, apoptosis, and autophagy. Therefore, in order to verify the protective effect of CC16, we injected different doses of rCC16 into a rat sepsis model to observe the corresponding changes.
General condition, survival percentage, vital signs and neurobehavioral scores were improved
We observed a general improvement in the condition of the rat sepsis model. At the same time, the survival percentage of the rat sepsis model increased to 26.7%, 46.7%, and 40% 48 h after the administration of different doses of rCC16 (P < 0.05, Fig. 1) , with different degrees of MAP increase and HR decrease (P < 0.05, Fig. 2C and D) ; their neurobehavioral scores also improved (P < 0.05, Fig. 3B ).
Pathological changes were reduced in the cortex and hippocampus
Subsequently, by microscopic observation of brain tissue sections, we found that at 12 h, compared with the rat sepsis model, structures of the cortex and hippocampus of the rat sepsis model treated with rCC16 were more organized, with increased cell number and alleviated edema (Fig. 10) .
Inflammation and oxidative stress were reduced in the supernatant of cortex and hippocampus
We continued to detect inflammation in brain tissue of the rat sepsis model after rCC16 treatment at 12 h, and found that IL-1β, IL-6, and TNF-α levels were decreased in the cortex and hippocampus, indicating an improved inflammatory response (P < 0.05, Fig. 11A ). Next, we tested the oxidative stress-related indicators and found that compared with the rat sepsis model, the inhibition rate of SOD in the cortex and hippocampus increased, while the level of MDA decreased after rCC16 treatment (P < 0.05, Fig. 11B ).
Decreased apoptosis in cortex and hippocampus
After continuous detection of relevant indicators, at 12 h, we found that the brain apoptosis in the rat sepsis model treated with rCC16 decreased; the expression of CC3 and Bax in the cortex and hippocampus decreased significantly (P < 0.05, Fig. 12A and B) , while that of Bcl-2 increased (P < 0.05, Fig. 12C ). In the cortex and hippocampus, the apoptosis rate of sepsis rats was significantly higher than that of sepsis mice treated with rCC16 (P < 0.05, Fig. 12D ).
Autophagy is further activated in the cortex and hippocampus
Western blot analysis results showed that after treatment with rCC16 at 12 h, the expression of LC3 II increased further, and the expression of SQSTM1/p62 decreased obviously in the cortex and hippocampus of the rat sepsis model was increased further (P < 0.05, Fig. 13A and B) ; TEM results revealed that compared to the CLP group, large autophagosomes were wrapped in organelle fragments and broken proteins in the CLP + 0.25 mg/kg rCC16 group; more small autophagic vesicles were present, encasing substances that were about to be completely degraded; also, autophagosomes were found to be decomposing into many small autophagic vesicles for further degradation (Fig. 13C) . Fig. 6 . Expression of CC3, Bcl-2, Bax and apoptosis rate in brain tissue after CLP surgery. A-C. CC3, Bcl-2, and Bax levels in the cortex and hippocampus were determined in the sham group and the CLP group at 3, 6, 12, 24, and 48 h. The values of protein levels were related to the signals obtained from tubulin protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs sham group in the cortex; # P < 0.05 vs sham group in the hippocampus. D. Annexin V-FITC/PI staining was performed in the cortex and hippocampus to observe apoptosis rates. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 in the cortex; # P < 0.05 in the hippocampus.
The p38MAPK signaling pathway was inhibited in cortex and hippocampus
The rCC16 could significantly inhibit the activation of the p38MAPK signaling pathway in the cortex or hippocampus of rats with sepsis at 12 h. Western blot analysis revealed that the expression of p-MAPKAPK2/MAPKAPK2 was decreased in brain tissues of the rat sepsis model treated with rCC16, and the changes in the cortex were more obvious than those in the hippocampus; these effects were found to be most significant at the rCC16 dose of 0.25 mg/kg (P < 0.05, Fig. 14) .
Effects of SB203580 or anisomycin continued after intervention with rCC16 in neonatal sepsis rats
After treatment with rCC16, the overall condition of the rat sepsis model was improved, and the pathological changes were alleviated. The P38MAPK signaling pathway in brain tissue was inhibited, and inflammation, oxidative stress, apoptosis, and autophagy were regulated. To further understand the association between these changes, we administered SB203580 or anisomycin in septic rats treated with rCC16. Fig. 7 . Expression of LC3 and SQSTM1/p62, and the observation of autophagy in brain tissue after CLP. A-B. LC3 and SQSTM1/p62 levels were determined in the cortex and hippocampus in the sham group and the CLP group at 3, 6, 12, 24, and 48 h. Values of protein levels were related to the signals obtained from the GAPDH protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs sham group in cortex; # P < 0.05 vs sham group in hippocampus. C. No pathological changes were observed in the cortical and hippocampal neurons in the sham group, whereas large autophagosomes (black arrows) containing organelles and proteins appeared in the CLP-12 h group, and the lysosomes (black arrows) invaded the organelles that were damaged and deformed. Scale bar indicates 10 μm. Fig. 8 . Expression of MAPKAPK2 and p-MAPKAPK2 in the brain tissue after CLP surgery. MAPKAPK2 and p-MAPKAPK2 expression were detected in the cortex and hippocampus of the sham-operated group and the CLP group at 3, 6, 12, 24, and 48 h. The protein levels were normalized to those of tubulin protein and are shown as relative arbitrary units. Data are expressed as means ± SEM, n = 6 in each group, *P < 0.05 vs expression in cortex of sham-operated group, # P < 0.05 vs expression in hippocampus of sham-operated group.
General condition, survival percentage, vital signs and neurobehavioral scores fluctuated
First, we observed that compared with the rat sepsis model treated with rCC16 only, SB203580 continued to improve the general condition of rats, and the survival percentage increased to 53.3% at 48 h after surgery (P < 0.05, Fig. 1 ); in addition, MAP continued to increase while HR continued to decrease (P < 0.05, Fig. 2C and D) , but neurobehavioral scores remained unchanged (Fig. 3B ). On the contrary, compared with the rat sepsis model treated only with rCC16, the general condition of rats further treated with anisomycin was worse, and Fig. 9 . Expression and localization of CC16 in the brains of sham-operated rats and the rat sepsis model. A. CC16 expression in the cortex and hippocampus of the sham-operated group and of rats at 3, 6, 12, 24, and 48 h after CLP. The protein levels were normalized to those of GAPDH protein and are shown as relative arbitrary units. Values are expressed as means ± SEM, n = 6 in each group, *P < 0.05 vs expression in cortex of sham-operated group, # P < 0.05 vs expression in hippocampus of sham-operated group. B. Immunofluorescence for CC16, and NeuN, GAPF, Olig2, and Iba1 co-staining in the cortex. C. Immunofluorescence for CC16, and NeuN, GAPF, Olig2, and Iba1 co-staining in the hippocampus. CC16 was dyed red, neurons were labeled with NeuN (green), astrocytes were labeled with GAPF (green), oligodendrocytes were labeled with Olig2 (green), microglia were labeled with Iba1 (green), and cell nuclei were labeled with DAPI (blue). Scale bar indicates 50 μm. D. In the brain, the ratio of CC16 and different nerve cells co-localization to the total amount of CC16 is shown in the histogram. Data are expressed as means ± SEM, n = 6 in each group, *P < 0.05 vs NeuN in sham-operated group, # P < 0.05 vs NeuN in CLP-12 h group. Fig. 10 . Effect of rCC16 treatment on the pathological changes in CLP rats at 12 h. HE staining was used to observe the cortex and hippocampus of the CLP group and the CLP + 0.25 mg/kg rCC16 group. Scale bar indicates 50 μm. n = 6 for each group.
the survival percentage dropped to 36.7% at 48 h after surgery (P < 0.05, Fig. 1) , with a decrease in MAP, increase in HR (P < 0.05, Fig. 2C and D) , and decrease in the neurobehavioral score (P < 0.05, Fig. 3B ).
Histopathologic changes in the cortex and hippocampus
At 12 h, after continuing to use SB203580, in the cortex and hippocampus, the number of cells increased slightly, with more regular arrangement and full cell morphology (Fig. 15 ). And when continued to use anisomycin, we observed that in the cortex and hippocampus, the number of cells decreased, the cell morphology was diverse, the cells were edematous and lightly stained, the structure was evacuated, the capillary collapsed, and the voids were slightly increased (Fig. 15 ).
Changes in inflammation and oxidative stress were observed in the supernatant of cortex and hippocampus
Meanwhile, we observed that at 12 h, after further administration of SB203580, the inflammatory responses in the brain tissue of rats did not considerably differ from those in the rat sepsis models with rCC16 intervention alone, but oxidative stress differed between the two groups. No significant differences were noted in the IL-1β levels in the cortex and hippocampus, while IL-6 levels were lower only in the hippocampus (P < 0.05, Fig. 16A ); TNF-α and MDA levels were lower in the cortex and hippocampus, while SOD inhibition rate was higher in the cortex and hippocampus (P < 0.05, Fig. 16A and B) . However, after further intervention with anisomycin, both inflammatory and oxidative stress were restored in rat brain tissue. Il-1β, IL-6 and TNF-α levels were significantly higher in the cortex and hippocampus (P < 0.05, Fig. 16A ), as was that of MDA, while SOD inhibition rate was lower (P < 0.05, Fig. 16B ). In addition, it is worth noting that there were no differences in brain inflammation and oxidative stress between the CLP group and the CLP + Veh group.
The phenomenon of apoptosis changed in cortex and hippocampus
We then measured apoptosis-related changes in the rat brain at 12 h. Western blot analysis revealed subsequent SB203580 administration did not elicit remarkable changes in brain apoptosis; CC3 and Bcl-2 expression in the cortex and hippocampus remained unchanged, while that of Bax only decreased slightly in the cortex (P < 0.05, Fig. 17A-C) , and the apoptosis rate was significantly reduced (P < 0.05, Fig. 17D ). However, with the continued use of anisomycin, apoptosis was reactivated to a significant extent; CC3 expression significantly increased and Bcl-2 expression significantly decreased in the cortex and hippocampus (P < 0.05, Fig. 17A and C) , while Bax expression significantly increased in the hippocampus (P < 0.05, Fig. 17B ). In addition, the apoptosis rate was significantly increased (P < 0.05, Fig. 17D ). In addition, apoptosis in the CLP + Veh group was not significantly different from that in the CLP group.
Autophagy changed in cortex and hippocampus
Finally, at 12 h, we analyzed autophagy in the rat brain. Subsequent SB203580 administration led to a further increase in LC3 II expression and a further decrease in SQSTM1/p62 expression. in the cortex and hippocampus (P < 0.05, Fig. 18A and B) . Under TEM, small autophagic vacuoles were occasionally observed, with relatively normal structure and intact organelles, in the CLP + rCC16 + SB group (Fig. 18C) . After subsequent anisomycin administration, LC3 II expression in the cortex and hippocampus decreased slightly, but that of Fig. 11 . Effect of rCC16 on levels of IL-1β, IL-6, TNF-α, SOD, and MDA in CLP rat brain tissue at 12 h. IL-1β, IL-6, TNF-α, SOD, and MDA levels were determined in the cortex and hippocampus. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP group in the cortex; # P < 0.05 vs CLP group in the hippocampus. SQSTM1/p62 remained unchanged (P < 0.05, Fig. 18A and B ). In the CLP + rCC16 + AN group, autophagy vesicles were observed at all stages, with large autophagosomes being predominantly observed along with severe organelle damage and disordered arrangement, as well as high cytoplasm lipid accumulation (Fig. 18C) . Meanwhile, autophagy of neurons in the CLP + Veh group was similar to that in the CLP group.
The activation effect of p38MAPK signaling pathway is obvious
We also tested whether the p38MAPK signaling pathway was affected under these conditions at 12 h. We found that there was no significant difference in p-MAPKAPK2/MAPKAPK2 between CLP + Veh group and CLP group. Compared with the intervention using rCC16 alone, the expression of p-MAPKAPK2/MAPKAPK2 in the cortex and hippocampus was not significantly changed after further administration of SB203580; however, the expression levels were significantly increased after further administration of anisomycin (P < 0.05, Fig. 19 ).
Discussion
We established a rat model for sepsis through CLP. The general condition of the CLP group was poorer than that of the sham-operated group, with decreased survival percentage, poor vital signs (MAP, HR), slow body movements, and pathological changes in the cortex and hippocampus, which can be considered to indicate the successful establishment of the sepsis model. The examination of corresponding indicators in the cortex and hippocampus revealed largely the same trends in the changes noted in these two regions.
Although sepsis has a diverse pathogenesis, an important component is the inflammatory cascade; immune disorders can lead to excessive cytokines and inflammatory mediator release after infection, resulting in autoimmune injury . Therefore, levels of inflammatory cytokines such as IL-1β, IL-6 and TNF-α during sepsis are closely related to prognosis (Zhang and He, 2018) . We observed that the levels of these cytokines in brain tissue in the CLP group were significantly higher than in the sham-operated group.
Disrupted balance between oxidative and antioxidant processes leads to oxidative stress and consequently an increase in free radical and active metabolite levels, which can damage cell and tissue structure (Kardeş et al., 2018) . Indicators of decreased antioxidant function include a decline in levels of SOD, which converts superoxide radical anions into hydrogen peroxide; and MDA, a highly active aldehyde, the final product of lipid peroxidation induced by free radicals and active metabolites (Hitchon and Elgabalawy, 2004; Mateen et al., 2016) . We observed that, owing to oxidative stress, the SOD inhibition rate in brain tissue in the CLP group was lower, while MDA levels were higher, than in the sham-operated group.
Apoptosis is a mechanism that maintains cell homeostasis (Daoud et al., 2018) . The CC3 is a downstream effector caspase which is activated in both the intrinsic and extrinsic apoptosis pathway, Bcl-2 and Bax mediates the endogenous pathway of apoptosis, and apoptotic bodies are specific manifestations of apoptosis. In our experiment, increased expression of CC3 and Bax and decreased expression of Bcl-2 in the CLP group, as well as increased proportion of apoptosis cells, can prove that apoptosis in the brain tissue during sepsis is intensified. Fig. 12 . Effect of rCC16 on expression of CC3, Bcl-2, Bax, and apoptosis rate in CLP rat brain tissue at 12 h. A-C. CC3, Bcl-2, and Bax levels in the cortex and hippocampus were determined by western blot. Values of protein levels were related to signals obtained from tubulin protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP group in the cortex; # P < 0.05 vs CLP group in the hippocampus. D. Annexin V-FITC/PI staining was performed in the cortex and hippocampus to observe apoptosis rates. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 in the cortex; # P < 0.05 in the hippocampus.
Excessive autophagy can destroy the normal structure of cells, leading to cell death (Galluzzi et al., 2012) . LC3II exists in the autophagosome membrane, and its content is closely related to the number of autophagosomes. Because of the conformational changes produced by the conjugation to phosphatidylethanolamine, the immunoreactivity of LC3II is higher than that of LC3I, and we only detected the expression of LC3II, rather than LC3II/LC3I (Mizushima and Klionsky, 2007) . SQSTM1/p62 selectively binds to the autophagosome component LC3 to form a polyubiquitinated protein polymer, which plays a role in regulation of a negative feedback loop in autophagy (Bjørkøy et al., 2005) . In this experiment, the expression of LC3II in CLP group decreased and that of SQSTM1/p62 increased, indicating enhanced autophagic activity. However, as per the TEM results, a large number of autophagic vacuoles encapsulating damaged organelles appeared in neurons, possibly because the process of autophagy was not fully activated and the inclusions could not be degraded.
MAPKAPK2 is one of the important substrates of p38MAPK and is independently regulated by p38MAPK-when p38 is specifically bound to MAPKAPK2, the p38MAPK signaling pathway is activated, followed by downstream molecular phosphorylation and consequent regulation of several cellular functions (Qian et al., 2016) . The total amount of MAPKAPK2 in the brain tissues of the CLP group did not differ from that in the sham-operated group, but p-MAPKAPK2 expression levels were significantly higher, suggesting that the p38MAPK pathway was activated during sepsis.
Studies on CC16 to date have largely focused on the lungs, but as it Fig. 13 . Effect of rCC16 on the expression of LC3 and SQSTM1/p62 and the observation of autophagy in CLP rat brain tissue at 12 h. A-B. LC3 and SQSTM1/p62 levels were determined by western blot. Values of protein levels were related to signals obtained from GAPDH protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP group in the cortex; # P < 0.05 vs CLP group in the hippocampus. C. In the cortex and hippocampus, the neurons in the CLP-12 h group mainly contained large undegraded autophagosomes (black arrow), while the neurons in the CLP + 0.25 mg/kg rCC16-12 h group were mainly contained small autophagy vesicles that were almost completely degraded (black arrow), or the autophagosomes decomposed into small autophagy vesicles, as can be seen (white arrow). Scale bar indicates 50 μm.
Fig. 14.
Effect of rCC16 on the expression of p-MAPKAPK2 and MAPKAPK2 in CLP rat brain tissue at 12 h. p-MAPKAPK2, MAPKAPK2 levels in the cortex and hippocampus were determined by western blot. Values of protein levels were related to the signals obtained from tubulin protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP group in the cortex; # P < 0.05 vs CLP group in the hippocampus.
is distributed throughout the body via the circulatory system (Hermans and Bernard, 1999) , we assessed brain CC16 in the present study. The present study is the first report of the localization of CC16 in the brain, closely associated with the neurons as well as with astrocytes, oligodendrocytes, and microglia. Meanwhile, the expression of CC16 in the CLP group was significantly lower than that in the sham-operated group. This suggests that the decrease of CC16 in brain tissue may be significant in sepsis. Some researchers have reported that the anti-inflammatory effect of CC16 is closely related to the p38MAPK signaling pathway (Pang et al., 2017) , which can regulates oxidative stress, apoptosis, and autophagy (Ma et al., 2014; Zhao et al., 2013; Liu et al., 2018) .
Our results showed that decreased expression of CC16 in the brain tissue of the rat sepsis model may lead to activation of the p38MAPK signaling pathway, causing pathological changes in brain tissue, increased inflammation, obvious oxidative stress, enhanced apoptosis, and incomplete activation of autophagy. In order to verify this interpretation and find a method to improve the brain tissue deterioration in the rat sepsis model, we selected the time point of 12 h and injected rCC16 into the lateral ventricle of the rats and analyzed the corresponding data. Compared with the CLP group, the general condition of the rat sepsis model treated with rCC16 improved, percentage of survival increased, body movement became more sensitive, and pathological changes in the brain tissue were alleviated. Meanwhile, the Fig. 15 . Effects of further use of SB203580 or anisomycin on the pathological changes in CLP rats treated with rCC16 at 12 h. HE staining was used to observe the cortex and hippocampus of the CLP + 0.25 mg/kg rCC16 group, CLP + rCC16 + SB group and CLP + rCC16 + AN group. Scale bar indicates 50 μm. n = 6 for each group in each experiment. Fig. 16 . Effects of further use of SB203580 or anisomycin on the levels of IL-1β, IL-6, TNF-α, SOD, and MDA in CLP rats treated with rCC16 at 12 h. IL-1β, IL-6, TNFα, SOD, and MDA levels were determined. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the cortex; # P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the hippocampus. p38MAPK signaling pathway was inhibited, inflammatory factor levels were decreased, oxidative stress was reduced, and apoptosis was inhibited. In addition, autophagy was activated, LC3II expression increased while SQSTM1/p62 expression decreased, and large autophagosomes divided into several small autophagic vacuoles, and the substances within the vesicles were hydrolyzed (Su et al., 2015; Huang et al, 2017) . Therefore, we can conclude that the overall vital signs of the rat sepsis model improved after rCC16 treatment, and rCC16 may have some significance in the treatment of sepsis.
To determine if the inhibitory effect of rCC16 on the p38MAPK signaling pathway and its regulation of inflammation, oxidative stress, apoptosis, and autophagy occur simultaneously, or if rCC16 re-regulates these processes through the p38MAPK signaling pathway, we used SB203580, an inhibitor of the p38MAPK signaling pathway, or anisomycin, an agonist, to observe the corresponding indicators. Compared with CLP + rCC16 group, the health status of the rats improved slightly, with improved vital signs, increased percentage of survival, no significant changes in body movement, and slight improvement in brain pathological changes, after continued use of SB203580. However, the p38MAPK signaling pathway was not significantly inhibited, levels of only IL-6 in the hippocampus and TNFα in the cortex and hippocampus were decreased, oxidative stress was reduced, and no obvious regulation of apoptosis was observed. Despite the relatively normal intracellular structure under TEM, expression levels of LC3II further increase while SQSTM1/p62 further decreased. It may be that autophagy is not only regulated by p38MAPK signaling pathway, but also affects other signaling pathways when inhibitors are used, leading to rapid degradation of substances during autophagy (Prabakaran et al., 2018; Li and Siragy, 2017; Xiao et al., 2017) . SB203580 showed no obvious effect on rats treated with rCC16, and this could be because rCC16 significantly inhibited the p38MAPK signaling pathway and inhibition by SB203580 could not be highlighted. At the same time, rCC16 regulates inflammation, oxidative stress, apoptosis, and autophagy through the p38MAPK signaling pathway, so its regulation of these processes is also not obvious.
Anisomycin treatment was continued in the rat sepsis model, and compared with the CLP + rCC16 group, the overall health status of the rats deteriorated; pathologic changes in the brain tissue worsened, the p38MAPK signaling pathway was reactivated, inflammatory reaction levels and oxidative stress increased, and apoptosis was reactivated. As Fig. 17 . Effect of further use of SB203580 or anisomycin on the expression of CC3, Bcl-2, Bax, and apoptosis rate in CLP rats treated with rCC16 at 12 h. A-C. CC3, Bcl-2, and Bax levels were determined by western blot. Values of protein data were related to signals obtained from tubulin protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the cortex; # P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the hippocampus. D. Annexin V-FITC/PI staining was performed in the cortex and hippocampus to observe apoptosis rates. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 in the cortex; # P < 0.05 in the hippocampus. Fig. 18 . Effect of further use of SB203580 or anisomycin on the expression of LC3 and SQSTM1/p62 and observation of autophagy in CLP rats treated with rCC16 at 12 h. A-B. LC3 and SQSTM1/p62 levels were determined by western blot. Values of protein data were related to signals obtained from GAPDH protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the cortex; # P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the hippocampus. C. In the cortex and hippocampus of the CLP + Veh group was similar to the CLP group in that large autophagy vesicles surrounded by broken organelles and proteins (black arrow) appeared in the cytoplasm. In the CLP + 0.25 mg/kg rCC16 group, there were small dual-mode autophagic vacuoles (black arrow), or the autophagosomes degraded into small autophagic vacuoles (white arrow). In the CLP + rCC16 + SB group, a small number of autophagic vesicles can be seen at the end of the autophagy process (black arrow). Intracellular lipid changes in the CLP + rCC16 + AN group, autophagic vesicles at different stages of the autophagy process (black arrow) can be seen. Scale bar indicates 50 μm. Fig. 19 . Effects of further use of SB203580 or anisomycin on the expression of MAPKAPK2 and p-MAPKAPK2 in CLP rats treated with rCC16 at 12 h. MAPKAPK2 and p-MAPKAPK2 levels were determined by western blot. Values of protein levels were related to signals obtained from tubulin protein and given as relative arbitrary units. Data were expressed as means ± SEM, n = 6 in each group; *P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the cortex; #P < 0.05 vs CLP + 0.25 mg/kg rCC16 group in the hippocampus. observed under TEM, the intracellular structure was disorganized, cytoplasm was lipidized, organelles were severely damaged, and all stages of autophagy were observed to be present at the same time. The level of LC3II decreased, possibly because the content of LC3II in the large autophagosome membrane was less than the sum of many small autophagic vesicle membranes during the degradation process, while the decrease of SQSTM1/p62 is not obvious, possibly because autophagy is activated and it is required to complete the ubiquitination binding in large quantities (Daniel et al., 2016) . In conclusion, we believe that the anisomycin treatment reactivates the p38MAPK signaling pathway, reverses the protective effect of rCC16 on a rat sepsis model, and proves that rCC16 regulates inflammation, oxidative stress, apoptosis, and autophagy by inhibiting the p38MAPK signaling pathway.
This study systematically demonstrated that CC16 plays a protective role in inflammation, oxidative stress, apoptosis and autophagy in newborn rats with SAE, and its pathway is related to the p38MAPK signaling pathway. As the disease progresses, when the amount of CC16 in SAE newborn rats gradually decreases, the injection of exogenous rCC16 into lateral ventricle earlier can effectively reduce brain injury. Therefore, further study on the biological effects of rCC16 is helpful for its application in clinical practice. However, in order to intuitively observe the effects of rCC16 on SAE rats' brain, the lateral ventricle injection pathway was adopted in this study, which was not conducive to the application of rCC16 in clinical practice. Therefore, intravenous injection and intraperitoneal injection could be tried in the following experiments for higher feasibility of drug delivery. In addition, this study only discussed the regulatory effect of CC16 on p38MAPK signaling pathway. However, the existing research confirms CC16 will also inhibit NF-κB signaling pathway, which closely associated with inflammation (Pang et al., 2015; Zhao et al., 2014) . And the inflammatory cascade reaction is one of the important onset sepsis process, therefore, to further explore CC16 mechanisms of sepsis, the study of NF-κB signaling pathway is indispensable.
Conclusion
In summary, CC16 was first identified and located in the brains of rats, which proved that CC16 was closely related to neurons. Additionally, CC16 levels significantly decreased in the brain of the rat sepsis model. rCC16 regulated inflammation, oxidative stress, apoptosis, and autophagy in the brain of the rat sepsis model by inhibiting the p38MAPK signaling pathway, thus improving the overall survival status of the rat sepsis model. Of note, whether rCC16 regulates other signaling pathways besides the p38MAPK signaling pathway to regulate inflammation, oxidative stress, apoptosis, and autophagy, has not been examined nor have the other possible effects (if any) of rCC16 on the rat sepsis model. Future studies need to further clarify the mechanism of action of rCC16 and identify a better drug delivery route and reasonable dosage as together they may allow for new therapeutic strategies for patients with sepsis.
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